TY - JOUR
T1 - The global burden of cancer attributable to risk factors, 2010–19
T2 - a systematic analysis for the Global Burden of Disease Study 2019
AU - GBD 2019 Cancer Risk Factors Collaborators
AU - Tran, Khanh Bao
AU - Lang, Justin J.
AU - Compton, Kelly
AU - Xu, Rixing
AU - Acheson, Alistair R.
AU - Henrikson, Hannah Jacqueline
AU - Kocarnik, Jonathan M.
AU - Penberthy, Louise
AU - Aali, Amirali
AU - Abbas, Qamar
AU - Abbasi, Behzad
AU - Abbasi-Kangevari, Mohsen
AU - Abbasi-Kangevari, Zeinab
AU - Abbastabar, Hedayat
AU - Abdelmasseh, Michael
AU - Abd-Elsalam, Sherief
AU - Abdelwahab, Ahmed Abdelwahab
AU - Abdoli, Gholamreza
AU - Abdulkadir, Hanan Abdulkadir
AU - Abedi, Aidin
AU - Abegaz, Kedir Hussein
AU - Abidi, Hassan
AU - Aboagye, Richard Gyan
AU - Abolhassani, Hassan
AU - Absalan, Abdorrahim
AU - Abtew, Yonas Derso
AU - Abubaker Ali, Hiwa
AU - Abu-Gharbieh, Eman
AU - Achappa, Basavaprabhu
AU - Acuna, Juan Manuel
AU - Addison, Daniel
AU - Addo, Isaac Yeboah
AU - Adegboye, Oyelola A.
AU - Adesina, Miracle Ayomikun
AU - Adnan, Mohammad
AU - Adnani, Qorinah Estiningtyas Sakilah
AU - Advani, Shailesh M.
AU - Afrin, Sumia
AU - Afzal, Muhammad Sohail
AU - Aggarwal, Manik
AU - Ahinkorah, Bright Opoku
AU - Ahmad, Araz Ramazan
AU - Ahmad, Rizwan
AU - Ahmad, Sajjad
AU - Ahmad, Sohail
AU - Ahmadi, Sepideh
AU - Ahmed, Haroon
AU - Ahmed, Luai A.
AU - Ahmed, Muktar Beshir
AU - Lee, Wei Chen
N1 - Publisher Copyright:
© 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license
PY - 2022/8/20
Y1 - 2022/8/20
N2 - Background: Understanding the magnitude of cancer burden attributable to potentially modifiable risk factors is crucial for development of effective prevention and mitigation strategies. We analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 to inform cancer control planning efforts globally. Methods: The GBD 2019 comparative risk assessment framework was used to estimate cancer burden attributable to behavioural, environmental and occupational, and metabolic risk factors. A total of 82 risk–outcome pairs were included on the basis of the World Cancer Research Fund criteria. Estimated cancer deaths and disability-adjusted life-years (DALYs) in 2019 and change in these measures between 2010 and 2019 are presented. Findings: Globally, in 2019, the risk factors included in this analysis accounted for 4·45 million (95% uncertainty interval 4·01–4·94) deaths and 105 million (95·0–116) DALYs for both sexes combined, representing 44·4% (41·3–48·4) of all cancer deaths and 42·0% (39·1–45·6) of all DALYs. There were 2·88 million (2·60–3·18) risk-attributable cancer deaths in males (50·6% [47·8–54·1] of all male cancer deaths) and 1·58 million (1·36–1·84) risk-attributable cancer deaths in females (36·3% [32·5–41·3] of all female cancer deaths). The leading risk factors at the most detailed level globally for risk-attributable cancer deaths and DALYs in 2019 for both sexes combined were smoking, followed by alcohol use and high BMI. Risk-attributable cancer burden varied by world region and Socio-demographic Index (SDI), with smoking, unsafe sex, and alcohol use being the three leading risk factors for risk-attributable cancer DALYs in low SDI locations in 2019, whereas DALYs in high SDI locations mirrored the top three global risk factor rankings. From 2010 to 2019, global risk-attributable cancer deaths increased by 20·4% (12·6–28·4) and DALYs by 16·8% (8·8–25·0), with the greatest percentage increase in metabolic risks (34·7% [27·9–42·8] and 33·3% [25·8–42·0]). Interpretation: The leading risk factors contributing to global cancer burden in 2019 were behavioural, whereas metabolic risk factors saw the largest increases between 2010 and 2019. Reducing exposure to these modifiable risk factors would decrease cancer mortality and DALY rates worldwide, and policies should be tailored appropriately to local cancer risk factor burden. Funding: Bill & Melinda Gates Foundation.
AB - Background: Understanding the magnitude of cancer burden attributable to potentially modifiable risk factors is crucial for development of effective prevention and mitigation strategies. We analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 to inform cancer control planning efforts globally. Methods: The GBD 2019 comparative risk assessment framework was used to estimate cancer burden attributable to behavioural, environmental and occupational, and metabolic risk factors. A total of 82 risk–outcome pairs were included on the basis of the World Cancer Research Fund criteria. Estimated cancer deaths and disability-adjusted life-years (DALYs) in 2019 and change in these measures between 2010 and 2019 are presented. Findings: Globally, in 2019, the risk factors included in this analysis accounted for 4·45 million (95% uncertainty interval 4·01–4·94) deaths and 105 million (95·0–116) DALYs for both sexes combined, representing 44·4% (41·3–48·4) of all cancer deaths and 42·0% (39·1–45·6) of all DALYs. There were 2·88 million (2·60–3·18) risk-attributable cancer deaths in males (50·6% [47·8–54·1] of all male cancer deaths) and 1·58 million (1·36–1·84) risk-attributable cancer deaths in females (36·3% [32·5–41·3] of all female cancer deaths). The leading risk factors at the most detailed level globally for risk-attributable cancer deaths and DALYs in 2019 for both sexes combined were smoking, followed by alcohol use and high BMI. Risk-attributable cancer burden varied by world region and Socio-demographic Index (SDI), with smoking, unsafe sex, and alcohol use being the three leading risk factors for risk-attributable cancer DALYs in low SDI locations in 2019, whereas DALYs in high SDI locations mirrored the top three global risk factor rankings. From 2010 to 2019, global risk-attributable cancer deaths increased by 20·4% (12·6–28·4) and DALYs by 16·8% (8·8–25·0), with the greatest percentage increase in metabolic risks (34·7% [27·9–42·8] and 33·3% [25·8–42·0]). Interpretation: The leading risk factors contributing to global cancer burden in 2019 were behavioural, whereas metabolic risk factors saw the largest increases between 2010 and 2019. Reducing exposure to these modifiable risk factors would decrease cancer mortality and DALY rates worldwide, and policies should be tailored appropriately to local cancer risk factor burden. Funding: Bill & Melinda Gates Foundation.
UR - http://www.scopus.com/inward/record.url?scp=85136218317&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85136218317&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(22)01438-6
DO - 10.1016/S0140-6736(22)01438-6
M3 - Article
C2 - 35988567
AN - SCOPUS:85136218317
SN - 0140-6736
VL - 400
SP - 563
EP - 591
JO - The Lancet
JF - The Lancet
IS - 10352
ER -